Top-News

Macrocure News

Keine aktuellen Kursdaten verfügbar
WKN: A119G8
ISIN: IL0011329435
Typ: Aktie

Macrocure News

26.04.22 - PR Newswire
MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022
MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022 PR Newswire
16.03.22 - PR Newswire
IIROC Trading Halt - MCUR
IIROC Trading Halt - MCUR Canada NewsWire
16.03.22 - PR Newswire
MINDCURE Provides Update on Strategic Review
MINDCURE Provides Update on Strategic Review PR Newswire
02.03.22 - PR Newswire
MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program
MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program PR Newswire
10.02.22 - PR Newswire
MINDCURE Announces Strategic Review
MINDCURE Announces Strategic Review PR Newswire
03.02.22 - PR Newswire
MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform
MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform PR Newswire
25.01.22 - PR Newswire
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022 PR Newswire
06.01.22 - PR Newswire
MINDCURE to Participate in the H.C. Wainwright Bioconnect Conference in January 2022
MINDCURE to Participate in the H.C. Wainwright Bioconnect Conference in January 2022 PR Newswire
20.12.21 - PR Newswire
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to ...
16.12.21 - PR Newswire
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022 PR Newswire
14.12.21 - PR Newswire
MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer
MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer PR Newswire
09.12.21 - PR Newswire
Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th
Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th Company executives will share corporate vision and answer audience questions at ...
02.12.21 - PR Newswire
MINDCURE to Participate in Upcoming Conferences in December 2021
MINDCURE to Participate in Upcoming Conferences in December 2021 PR Newswire
04.11.21 - PR Newswire
MINDCURE Provides Update on Studies and Clinical Trials
MINDCURE Provides Update on Studies and Clinical Trials PR Newswire
28.10.21 - PR Newswire
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, ...
27.10.21 - PR Newswire
MINDCURE Announces Participation at Upcoming Events in November 2021
MINDCURE Announces Participation at Upcoming Events in November 2021 PR Newswire
07.10.21 - PR Newswire
MINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021
MINDCURE to Webcast Live at the KCSA Psychedelics Virtual Investor Conference on October 13, 2021 PR Newswire
30.09.21 - PR Newswire
MINDCURE Announces Commencement of Trading on the OTCQX Best Market
MINDCURE Announces Commencement of Trading on the OTCQX Best Market PR Newswire
28.09.21 - PR Newswire
MINDCURE to Present at the Benzinga Healthcare Small Cap Conference
MINDCURE to Present at the Benzinga Healthcare Small Cap Conference PR Newswire
27.09.21 - PR Newswire
MINDCURE Launches "Desire Project" To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy
MINDCURE Launches "Desire Project" To Treat Female Hypoactive Sexual Desire Disorder With MDMA-​Assisted Psychotherapy PR Newswire

Newssuche

Videos

25.04.24 +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »